Insulin Resistance and Insulin Secretion
Withdrawn before enrolling · Not applicable
Conditions studied: Diabetes Mellitus, Type 2
In brief
This is a pilot study to examine the prevalence of metabolic risk factors (impaired insulin release and impaired insulin sensitivity) for type 2 diabetes mellitus in children and adults from a population that is at high risk for this disease. We hypothesize that at least one of these pre-diabetic traits will be evident in a large proportion of relatives of known type 2 diabetic children as compared to a control group of subjects without a family history of type 2 diabetes. By isolating these traits, it will be possible to determine the relative contributions of genes and environment to each trait and to identify those at risk for subsequent development of type 2 diabetes by virtue of having one trait. Ultimately, those individuals at risk, especially those with impaired insulin release, would hopefully benefit from intervention to prevent the weight gain that will 'unmask' their underlying pancreatic dysfunction and thus prevent or retard the development of type 2 diabetes.
Key facts
- Study ID
- NCT00073294
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- People needed
- 0
- Last updated by the study team
- 2018-03-02
Who can join
Age: 10 and older, up to 20. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Columbia Presbyterian Medical Center/ Irving Center — New York, New York, United States
- Russ Berrie Pavilion — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.